Decibel Therapeutics, Inc. Operating Lease Cost
Decibel Therapeutics, Inc. reported Operating Lease Cost of $1.46 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2023-08-11
- Decibel Therapeutics, Inc. operating lease, cost for the quarter ending 2023-06-30 was $729.00K, a 0.00% change year-over-year.
- Decibel Therapeutics, Inc. operating lease, cost for the quarter ending 2023-03-31 was $729.00K, a 0.00% change year-over-year.
- Decibel Therapeutics, Inc. operating lease, cost for the quarter ending 2022-12-31 was $730.00K.
- Decibel Therapeutics, Inc. operating lease, cost for the quarter ending 2022-09-30 was $729.00K.
- Decibel Therapeutics, Inc. operating lease, cost for fiscal 2022 was $2.92M, a 143.08% increase from fiscal 2021.
- Decibel Therapeutics, Inc. operating lease, cost for fiscal 2021 was $1.20M, a 25.00% decline from fiscal 2020.
- Decibel Therapeutics, Inc. operating lease, cost for fiscal 2020 was $1.60M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-06-30 | $729.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.46M 10-Q · filed 2023-08-11 | $2.19M derived: sum of 3 quarters · filed 2023-08-11 | $2.92M derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $729.00K 10-Q · filed 2023-05-15 | $1.46M derived: sum of 2 quarters · filed 2023-05-15 | $2.19M derived: sum of 3 quarters · filed 2023-05-15 | $2.92M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | $730.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.46M derived: sum of 2 quarters · filed 2023-03-14 | $2.19M derived: sum of 3 quarters · filed 2023-08-11 | $2.92M 10-K · filed 2023-03-14 |
| 2022-09-30 | $729.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.46M derived: sum of 2 quarters · filed 2023-08-11 | $2.19M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $729.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.46M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $729.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $1.20M 10-K · filed 2022-03-18 | |||
| 2020-12-31 | $1.60M 10-K · filed 2022-03-18 |